Page 8 - Rheumatology Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study finds a subset of vascular macrophages to be powerful ally in the fight against atherosclerosis

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters "good" macrophage behavior within the vessel wall.

Emily hendersonNature communicationsNovo nordisk postdoctoral researchUniversity of oxfordKennedy institute of rheumatologyEuropean commissionKennedy trust for rheumatology researchKennedy instituteNovo nordisk foundationNovo nordisk postdoctoral research fellowClaudia monacoCardiovascular inflammationKennedy trustRheumatology researchNovo nordiskCardiovascular disease

Cannabis extract to be used to treat diabetes

Cannabis extract to be used to treat diabetes
israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.

Israel generalUnited statesUnited kingdomHebrew universityAbigail klein leichmanRaphael mechoulamMarc feldmanLola weissRuth gallilyMarkj rosenfeldChaim lotanRonen durstKennedy trust for rheumatology researchHebrew university of jerusalemHadassah university medical centerHadassah medical organization

Research reveals new clues for shared origins of irritable bowel syndrome and mental health disorders

An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same

United kingdomInstituto salud carlosLuke jostinsNick kennedyChris eijsboutsMauro damatoMe incUniversity of oxfordHealth department of the basque governmentBiomedical research centres in cambridgeUniversity of cambridgeKennedy trust for rheumatology researchNational institute for health researchLi ka shing foundationUniversity oxfordSwedish research council vetenskapsradet

New Comprehensive Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Provided Durable Improvements in Measures of Psoriatic Arthritis (PsA) Disease Activity Through Two Years

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced comprehensive efficacy and safety data from the DISCOVER–2 trial of.

British columbiaSpring houseUnited statesJennifer mcintyreAlyssa johnsenDonvitot creakyjointsPhilip measeBridget kimmelZismand comorbiditiesItem short form survey physical component summaryAmerican college of rheumatologyJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonUniversity of washington school medicineNational psoriasis foundation

Global Cardiovascular Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021

Global Cardiovascular Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomEmory universityKyonggi doSouth koreaMassachusetts institute of technologyNational university of singaporeSingapore generalHealth sciences centerNew yorkCharles riverCalifornia institute of technologyColumbia universityNew brunswickCity ofLa jolla